Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Celo is an app-based insurance provider designed to provide cheaper quotes, faster claims, and a pleasant user experience. We plan to offer insurance cover for motor vehicles, travel, health, and more. Like Monzo and Starling who are disrupting banking, Celo plans to disrupt the insurance industry.
days to go:
Expired
investment:
£142,840
Electric Assisted Vehicles Limited or EAV is a new generation vehicle design and manufacturing company providing a world-class solution. In August, the company has been revealed at the UK EV summit in Oxford. DPD is the technical partner of EAV and it has issued Letter of Intent for 50 more EAVans. With the proceeds, the company will expand into the international market, develop the product and will set its business lease plans.
days to go:
Expired
investment:
£215,130
Agile Store Builder allows you create your very own worldwide network of multiple stores by country, language, domain and product. These are all collectively managed in one system. You can also create stores for partners and affiliates to sell your products on a commission basis.
days to go:
Expired
investment:
£261
Cannabrew is one of the UK's first Cannabidiol (CBD) infused craft beers. It aspires to become a contender in the CBD market that is expected to reach £1 billion by 2025 in the UK. The company has sold thousands of cans across the UK despite COVID-19 and aims to become carbon-neutral soon. It assets that it plants two trees for every case of beer sold and has planted over 14,000 trees through a sustainability initiative in Madagascar by partnering with 'Ecologi', removing an estimated 350 tonnes of CO2 in just six months since the company's launch. Cannabrew was nominated for three awards at the World CBD Awards. Its product, Soul Lager, has become the highest-rated lager on Untappd in the UK achieving a score of >3.96. The company will use 25% of the investment in marketing, 50% towards team expansion, and 25% to scale production and boost New Product Development (NPD).
days to go:
Expired
investment:
£216,695
KindLink are a social network for donors and charities so donors are able to make a donation to their favourite charity and help them help other people. Donors are able to see the impact of the donations they are making by following the progress of the charity and updates for the project donated to. KindLink establishes a direct connection between donor and beneficiary to create a close and community-like feel.
days to go:
Expired
investment:
£25,045
